Correction: Rapid treatment center for depression in China: constructive reflections and transnational implications
Zhan-Ming Shi, Xing-Bing Huang, Yan-Ling Zhou, Yu-Ping Ning, Gabor S. Ungvari, Yu-Tao Xiang, Wei Zheng
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMental Health Treatment and Access · Treatment of Major Depression · Digital Mental Health Interventions
A correction has been made to the section 3 Actionable recommendations, 3.1 Electroconvulsive therapy, Paragraph 1. The sentence previously stated:
“Because of its relatively moderate efficacy rate of approximately 60.0% (10) and known neurocognitive side effects (11), there are ongoing efforts aiming at refining the clinical application of ECT from various perspectives, including anesthetic selection, stimulation dosage, electrode placement and apnoeic oxygenation.”
The corrected sentence appears below:
“Because of its relatively moderate efficacy rate of 58% and 70%, for those with and without medication failure, respectively (10) and known neurocognitive side effects (11), there are ongoing efforts aiming at refining the clinical application of ECT from various perspectives, including anesthetic selection, stimulation dosage, electrode placement and apnoeic oxygenation.”
A correction has been made to the section 3 Actionable recommendations, 3.3 Magnetic seizure therapy, Paragraph 1. The sentence previously stated:
“Capitalizing on its advantageous profile of reduced neurocognitive side effects and comparable antidepressant efficacy to ECT (52), a team at Beijing Anding Hospital of Capital Medical University, have adopted an accelerated MST protocol termed daily MST, demonstrating rapid antidepressant effects (53).”
The corrected sentence appears below:
“Capitalizing on its advantageous profile of comparable antidepressant efficacy to ECT (52), a team at Beijing Anding Hospital of Capital Medical University have adopted an accelerated MST protocol termed daily MST, demonstrating rapid antidepressant effects (53).”
A correction has been made to the section 4 Discussion, 4.2 Comparisons of rapid antidepressant treatments, Paragraph 1. The sentences previously stated:
“A recent meta-analysis of six RCTs comparing the efficacy and safety of ECT with ketamine revealed no significant disparity between the two treatments (82). Conversely, another meta-analysis (83) concluded that ketamine, regardless of its administration route, surpassed ECT in effectiveness for MDD patients.”
The corrected sentences appear below:
“A recent meta-analysis supported the use of ECT over ketamine for inpatients (82). Conversely, another meta-analysis of RCTs comparing the efficacy of ECT with ketamine revealed no significant disparity between the two treatments (83).”
A correction has been made to the section 4 Discussion, 4.3 General/systemic deficiencies, Paragraph 2. The sentence previously stated:
“In rural regions, only 5.1% of patients with MDD received any healthcare treatment, compared to 8.9% in urban areas (89).”
The corrected sentence appears below:
“In rural regions, only 5.1% of patients with depressive disorders received any form of healthcare treatment, compared to 8.9% in urban areas (89).”
The original version of this article has been updated.